医学
疾病
生物标志物
内科学
肿瘤科
临床试验
梅德林
生物信息学
动力学(音乐)
多中心研究
作者
Wang Liao,Qun Yu,Bin Chen,Hualin Chen,Liangyu Zou,Haiqun Xie,Haobo Chen,Chenyang Wang,Yiming Li,Xiaoya Gao,Hongbo Guo,Ying Yang,Ziyu She,Qinggan Zeng,Zengqiang Zhang,Guihua Li,Shujun Feng,Han Lin,Jipeng Ouyang,Junyan Liang
摘要
Lecanemab was effective and well tolerated in real-world Chinese patients. Plasma p‑tau217 may serve as a sensitive, minimally invasive treatment-response biomarker.
科研通智能强力驱动
Strongly Powered by AbleSci AI